NCT00745108View on ClinicalTrials.gov

Tibolone Endometrium Study (Study 32972)(P06470)

PHASE3CompletedINTERVENTIONAL
Enrollment

32

Participants

Timeline

Start Date

October 1, 2001

Primary Completion Date

July 21, 2005

Study Completion Date

July 21, 2005

Conditions
Postmenopausal Women
Interventions
DRUG

tibolone

oral 1.25 mg tablet, once daily, for 2 years

DRUG

Tibolone 2.5 mg

oral 2.5 mg tablet, once daily, for 2 years

DRUG

CE/MPA

oral, 0.625 mg tablet conjugated equine estrogen and 2.5 mg medroxyprogesterone acetate tablet placed together in a single capsule, once daily, for 2 years

All Listed Sponsors
lead

Organon and Co

INDUSTRY

NCT00745108 - Tibolone Endometrium Study (Study 32972)(P06470) | Biotech Hunter | Biotech Hunter